Craneware plc (LON:CRW - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,975.56 ($26.81) and traded as high as GBX 2,250 ($30.53). Craneware shares last traded at GBX 2,130 ($28.90), with a volume of 20,896 shares changing hands.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on CRW shares. Shore Capital reiterated a "buy" rating on shares of Craneware in a research report on Thursday, May 8th. Berenberg Bank reiterated a "buy" rating and set a GBX 2,800 ($37.99) price objective on shares of Craneware in a research report on Tuesday, March 11th.
View Our Latest Report on CRW
Craneware Price Performance
The stock has a fifty day moving average price of GBX 1,777.53 and a 200-day moving average price of GBX 1,976.55. The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The company has a market cap of £859.93 million, a PE ratio of 73.94 and a beta of 0.28.
Craneware Cuts Dividend
The business also recently declared a dividend, which was paid on Thursday, April 17th. Investors of record on Thursday, March 20th were issued a GBX 13.50 ($0.18) dividend. This represents a dividend yield of 0.71%. The ex-dividend date was Thursday, March 20th. Craneware's dividend payout ratio is currently 107.14%.
Insider Activity at Craneware
In related news, insider Will Whitehorn purchased 1,911 shares of the stock in a transaction that occurred on Thursday, April 24th. The stock was acquired at an average price of GBX 1,584 ($21.49) per share, with a total value of £30,270.24 ($41,072.24). 19.28% of the stock is currently owned by company insiders.
Craneware Company Profile
(
Get Free Report)
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
Read More
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
